About Calcifying Nanoparticles

Nanobacteria, also known as Calcifying Nanoparticles (CNPs) form a calcium phosphate armor identical to harmful deposits found in diseases such as atherosclerosis, kidney stones, prostatitis, breast cancer, and ovarian cancer.

No other particle is known to manufacture such a calcified coating under human blood conditions, and until now medical science has never been able to prove why such calcification occurs in disease.

Aside from being toxic on its own, the calcium phosphate layer binds proteins that have been implicated in disease.

Calcifying Nanoparticles have been detected in urine and kidney stones, bile and gall bladder stones, atherosclerotic plaques, heart valves, Polycystic Kidney Disease cysts, liver cysts and human & fetal bovine serum.

Our company is focused on finding whether eradicating CNPs can help treat or prevent disease. We are investigating whether drug combinations effective against CNPs in vitro have the same effectiveness in human patients.

Our research suggests that CNPs participate in many pathological events such as thrombosis, autoimmune response, inflammation & cell proliferation, altered cell functions, pathological calcification & cell death.

A recent study by Mayo Clinic showed that CNPs play a role in cardiovascular diseases such as heart valve calcification and atherosclerosis.

Researchers at Washington Hospital Center have shown that antibodies against CNPs are a risk factor for coronary artery calcification, which is known to be the best predictor for future myocardial infarction.

CNPs have also been detected in ovarian cancer.

Nanobac Pharmaceuticals, Inc.
3000 Bayport Drive, Suite 910
Tampa, Florida 33607
Ph. (813) 865-1125

Email us at: